Endpoint definition
↥| Name | RX_GLUCOSAMINE |
|---|---|
| Long name | Glucosamine medication |
| Medicine purchases: ATC codes | M01AX05 |
| First defined in version | DF5 |
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 11199 | 7991 | 3208 |
| Unadjusted prevalence (%) | 5.16 | 6.50 | 3.41 |
| Mean age at first event (years) | 60.67 | 60.49 | 61.14 |
| Case fatality at 5-years (%) | 1.68 | 1.26 | 2.71 |
Longitudinal metrics
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 2.0 | 2.0 | 2.0 |
| Recurrence at 6 months (%) | 51.84 | 54.37 | 46.71 |
Survival analyses between endpoints
↥Plot
before Glucosamine medication
after Glucosamine medication
Loading survival analyses plot…
Table
Loading survival analyses table…